Rowland Carmichael Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Rowland Carmichael Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$600K	Hold	9,667	–	–	0.19%	121
2020 Q3	$583K	Buy	9,667 +51	+0.5%	+$3.07K	0.23%	112
2020 Q2	$565K	Sell	9,616 -299	-3%	-$17.9K	0.24%	107
2020 Q1	$553K	Buy	+9,915	New	+$606K	0.28%	103
2017 Q1	–	Sell	-16,222	Closed	-$948K	–	286
2016 Q4	$948K	Sell	16,222 -839	-5%	-$45.9K	0.56%	55
2016 Q3	$920K	Sell	17,061 -353	-2%	-$22.7K	0.59%	61
2016 Q2	$1.28M	Buy	17,414 +1,483	+9%	+$105K	0.81%	26
2016 Q1	$1.02M	Buy	+15,931	New	+$1M	0.94%	25

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rowland Carmichael Advisors's BMY Position: Q4 2020 in Review

Rowland Carmichael Advisors held its Bristol-Myers Squibb (BMY) position steady in Q4 2020 at 9,667 shares worth $600K. The position accounts for 0.19% of the portfolio, ranked #121.

Rowland Carmichael Advisors first reported a position in BMY in Q1 2016 and has held it in 8 quarters since. The position peaked at $1.28M in Q2 2016. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Rowland Carmichael Advisors held 9,667 shares of Bristol-Myers Squibb worth $600K as of Q4 2020.
Rowland Carmichael Advisors left its Bristol-Myers Squibb share count unchanged in Q4 2020.
Bristol-Myers Squibb made up 0.19% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #121 holding.
Rowland Carmichael Advisors first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 8 quarters since.
Rowland Carmichael Advisors's Bristol-Myers Squibb position peaked at $1.28M in Q2 2016.
2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.